1st January 2015
Oxford Optronix welcomes in 2015 with much to look forward to.
We’re committed to an initial batch of select shows and conferences at which we will be continuing to turn heads with our unique take on hypoxia workstations – the new HypoxyLab system – as well as meeting with existing and prospective clients of our hugely popular next-generation OxyLite oxygen monitors and our GelCount colony analyzer.
With in excess of 120 peer-reviewed citations and over 150 units sold worldwide, GelCount has become a true ‘gold standard’ in cancer biology colony counting.
Our latest product HypoxyLab, too, has proved popular around the world; indeed we have had to draft in additional personnel to meet demand. In the next couple of months we will be dispatching our first units to eager customers in territories outside of Europe and the US, including Brazil, Qatar, China and Russia. A good product knows no borders and we’re delighted with the response we’re seeing to our entry into this market, with a hypoxia workstation that is compact and economical, yet that sets new standards in simplicity, performance and features.
2015, we hope, will mark major milestones in our ongoing academic partnerships. Our most ambitious target is to achieve CE marking for our bladder wall oxygen monitoring technology before the end of the year, in preparation for clinical trials commencing 2016. This project is generously funded by the NIHR/Wellcome Health Innovation Challenge Fund.
We are also looking forward to reaching the proof of principle stage this year with our Wellcome Trust / EPSRC funded Acute Respiratory Distress Syndrome (ARDS) project – a long-standing collaboration between Oxford Optronix and Oxford University.
Elsewhere, we have an R&D pipeline that’s bursting at the seams. 2015 will see numerous incremental product improvements filtering through across our whole product range. These will be announced on this news page, in our newsletters, as well as on our Facebook and Twitter feeds.
It’s 2015 – the ‘future’ as envisioned in the 1989 movie “Back To The Future Part II”.
Self-tying sneakers? Hoverboards? Check out which predictions the movie got right!
26th May 2021
29th April 2021
A sensor for detecting faecal incontinence
13th April 2021
14th March 2021
Our ColCount product cameos in a Hollywood movie!
22nd December 2020
A year like no other
7th December 2020
HypoxyLab™: You spoke. We listened
2nd June 2020
22nd April 2020
Oxford Optronix builds 2000 Flo-Ox™ monitors in 8 days!
16th March 2020
Business continuity statement / COVID-19 pandemic
6th January 2020
Here comes 2020
11th April 2019
WellBeing™ clinical trials commence
5th February 2019
2nd January 2019
Happy New Year!
16th October 2017
Ed Vaizey MP visits Oxford Optronix
2nd June 2017
Welcome to our new website!
12th May 2017
Spring has sprung
1st December 2016
Reflecting on 2016; looking forward to 2017
1st October 2016
A little time Down Under…
1st April 2016
Latest GelCount software update
1st February 2016
Guest post by John Coyle, Business Development Principle
1st January 2016
Announcing a mutual distribution deal with Baker Ruskinn
1st December 2015
Asia distributor workshop
1st June 2015
Performance updates for HypoxyLab
1st March 2015
Meet us at Genes & Cancer UK, Cambridge
1st January 2015
Looking forward to a busy 2015
1st November 2014
Oxford Optronix reaches new customers
1st April 2014
Guest post by Michael Rau, Director of Sales
1st March 2014
Strategic tie-up with SciPro Inc., USA
1st February 2014
Single-channel OxyFlo™ now shipping
1st January 2014
GelCount™ software update
1st December 2013
Reflections on 2013
1st November 2013
Autumn conference round-up
1st October 2013
Our 2013 Customer Survey results are out
1st July 2013
Announcing our newly commissioned cleanroom
1st June 2013
A report on conferences attended in 2013 so far
1st February 2013
Next-generation OxyLite™ and OxyFlo™ monitors